Approved for INDICATIONS AND USAGE Prevnar ® is indicated for active immunization of infants and toddlers against invasive disease caused by S. pneumoniae due to capsular serotypes included in the vaccine (4, 6B, 9V, 14, 18C, 19F, and 23F). The routine schedule is 2, 4, 6, and 12-15 months of age. The decision to administer Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM 197 Protein),…
Loading full data from Know Your Drugs Institute…